Cardiff University and Cardiff & Vale UHB have a long and established track record of working together to deliver exceptional services through cutting edge innovation.
The Clinical Innovation Partnership is a creative initiative aimed at delivering better patient healthcare and wealth creation in Wales. The agreement between Cardiff and Vale University Health Board and Cardiff University strengthens a commitment to deliver better patient healthcare and boost the economy in Wales. It aims to accelerate the translation of clinical innovation into improvements in health and clinical services.
Based on a long-standing relationship, the agreement brings both organisations closer to work on a range of challenges including:
- tackling dementia – exploiting joint academic and clinical expertise across the UHB and the University
- developing innovative products and services for better health outcomes
- improving diagnostics linked to precision medicine
The Partnership has been formalised through a Clinical Innovation Strategy. It will:
- establish an approach to supporting ideas to improve patient care from clinicians, academics and students
- provide robust processes for supporting ideas that translate into new products and services
- build on the multidisciplinary meetings which provide a dynamic team with membership tailored to requirements of the ideas presented. The team co-opts experts from academia, NHS, industry and professional services. The team is able to support and advise on all elements of projects and ideas, enabling innovators to harness, accelerate and protect great innovative ideas.
Through the innovative exploitation of combined expertise and research activity, Cardiff University and Cardiff and Vale University Health Board (C&V UHB) are working to improve health and well-being whilst delivering wider economic benefits.
The collaboration aims to tackle major health challenges such as dementia which require a detailed knowledge of disease processes, diagnosis, treatment and social care issues. Collaboration – and engagement with national initiatives – is a key part of the strategy.
These case studies highlight just some of the areas in which our clinical innovation is delivering positive impact:
For more information, please contact us: